Biospecimen, Metabolomics, and Pathology Core for Endometrial Cancer Research
Official title: Core 2: Biospecimen, Metabolomics, and Pathology Core
Funded at Washington University · NIH-11421871 · Data updated 2026-11-12
A national, multi-institutional resource collects and analyzes tissue, blood, and metabolites from endometrial cancer patients to support multiple research projects.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project start | August 23, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $212,524 |
| NIH project number | 5P50CA265793-04 |
| Project ID | NIH-11421871 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with endometrial cancer at participating institutions who consent to biospecimen collection and associated data use.
✕Less likely to help
Patients outside the participating sites or those who do not consent to sample collection may not directly benefit.
What this research studies
This core provides high-quality biospecimens, metabolomic analyses, and expert pathology reviews to endometrial cancer studies. It will build a shared biospecimen bank across participating centers and connect with existing clinical data systems. The work includes standardized sample processing, data interoperability, and access to specialized metabolomics facilities to accelerate translational research. Researchers and patients may benefit from better-derived biomarkers and more robust studies enabled by this resource.
Why it matters
Potential benefit: If successful, the core could speed up discovery of biomarkers and improve understanding of endometrial cancer through well-annotated specimens and analyses.
How similar studies have gone: Biospecimen banks and metabolomics cores have enabled important cancer biomarker discoveries in prior projects.
Where this research is happening
-
Washington University
Saint Louis, United States Active
Researchers
- Principal investigator: Hagemann, Ian S. — Washington University
- Study coordinator: Hagemann, Ian S.
Related research
Other NIH-funded projects on the same topics.
-
Newborn screening: using gene and metabolite data to refine true vs false positives
A study using genetic and metabolomic data from newborn blood spots to better distinguish real metabolic disorders from false alarms.
-
IDEAL: How early-life immune development shapes vaccine responses and asthma risk
A child-focused project that looks at how the developing immune system in early life affects vaccine responses, respiratory infections, and asthma.
-
Integrative metabolomics to improve sarcoidosis diagnosis and prognosis
A research project from UCLA aims to find blood-based biomarkers that help diagnose sarcoidosis earlier and predict how it will progress, especially in African American women.
-
Metabolomics clues to how ultra-processed foods affect risk of type 2 diabetes
A scientist-led study will look at how eating different ultra-processed foods may change diabetes risk by using a controlled feeding trial and big population data, focusing on adults.
-
Longitudinal metabolomics in infants with food allergies
A study in infants aims to understand how gut metabolites relate to the development of food allergies, including IgE-mediated and non-IgE cases.
-
Metabolomics core to map liver metabolism in liver cancer
A core facility will measure liver metabolism and metabolic flux to help understand how liver cancer develops and to guide new treatments.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.